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ABSTRACT  The biochemical signaling pathways involved in nitric oxide  (NO)- 
mediated cholinergic inhibition of L-type Ca  2+ current  (Ic,  tL1) were investigated 
in isolated primary pacemaker cells from the rabbit sinoatrial node (SAN) using 
the  nystatin-perforated  whole-cell  voltage  clamp  technique.  Carbamylcholine 
(CCh; 1 v.M), a stable analogue of acetylcholine, significantly inhibited/C~<L) after 
it had been augmented by isoproterenol (ISO; 1 ~M). CCh also activated an out- 
ward K + current, IKC^Ch)-  Both of these effects of CCh were blocked completely by 
atropine.  Preincubation  of  the  SAN  cells  with  L-nitro-arginine  methyl  ester 
(L-NAME;  0.2-1  mM), which  inhibits NO synthase  (NOS),  abolished  the  CCh- 
induced attenuation of/C~r  but had no effect on IaC^Ch). Coincubation of ceils with 
both L-NAME and the endogenous substrate ofNOS, L-arginine (1 mM), restored 
the CCh-induced attenuation of/C,r  indicating that L-NAME did not direcdy in- 
terfere with the muscarinic action of CCh on IC~CL). In the presence of ISO the 
CCh-induced  inhibition  of IC~r  could  be mimicked by the  NO  donor  3-mor- 
pholino-sydnonimine (SIN-l; 0.1  mM). SIN-1 had no effect on its own or after a 
maximal effect of CCh had developed, indicating that it does not inhibit Ice,L) di- 
rectly. SIN-1 failed to activate Ig(^Ch), demonstrating that it did not activate musca- 
rinic receptors. Both CCh and NO are known to activate guanylyl cyclase and ele- 
vate intracellular cGMP. External application of methylene blue (10 ItM), which 
interferes with the ability of NO to activate guanylyl cyclase, blocked the CCh-in- 
duced attenuation of/C~r  However, it also blocked the activation of IKCACh), sug- 
gesting an additional  effect on muscarinic receptors or G  proteins. To address 
this, a  separate series of experiments was performed using conventional whole- 
cell recordings with methylene blue in the pipette. Under these conditions, the 
CCh-induced attenuation of IC~r  was blocked, but the activation of IgCACh) was 
still  observed.  Methylene  blue  also  blocked  the  SIN-l-induced  decrease  in 
IC~tL). 6-anilino-5,8-quinolinedione  (LY83583;  30  tzM),  an  agent  known  to  de- 
crease both basal and CCh-stimulated cGMP levels, prevented the inhibitory ef- 
fects of both CCh and SIN-1 on/C~r  but had no effect on the activation of IK(ACh) 
by CCh. In combination, these results show that CCh- and NO-induced inhibition 
of IC~r  is mediated by cGMP. CCh could not decrease/CaCL) after it had been in- 
creased maximally by a  membrane-permeable cAMP analogue,  8-(4-chlorophe- 
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nylthio)-adenosine-3',5'-cyclic monophosphate  (8-CPT-cAMP; 0.2 mM), which is 
resistant  to the cAMP-specific phosphodiesterase  (PDE). This finding suggests 
that  neither  the  cAMP-dependent protein  kinase  (PKA) nor  the  biochemical 
events occurring subsequent to PKA activation are involved in the CCh- or NO-in- 
duced inhibition of Ica(L). ICa(L) was not changed significantly  by the membrane- 
permeable  cGMP analogues  8-bromognanosine-3',5'-cyclic  monophosphate  (8- 
Br-cGMP; 0.25-0.5 raM) and 8-(4-chlorophenylthio)-guanosine-3',5'-cyclic mono- 
phosphate (8-CPT-cGMP; 0.25 mM). These compounds selectively activate cGMP- 
dependent protein kinase (PKG); their effects therefore rule out a role of PKG in 
this NO-mediated, CCh-induced inhibition of IcatL ). A potent but nonspecific PDE 
inhibitor 3-isobutyl-l-methyl-xanthine (IBMX; 20 o,M) completely prevented the 
CCh-induced attenuation of/Ca(L). Taken together, these findings suggest that in 
mammalian primary pacemaker SAN cells (in the presence of ISO), NO-mediated 
cholinergic inhibition  of ICa(L) is due to a cGMP-stimulated  cAMP-specific PDE, 
which hydrolyzes cAMP and  thus inhibits cAMP-dependent phosphorylafion of 
ICa(L )  channels.  Since /Ca(L)  is essential for normal  pacemaker activity, this  bio- 
chemical pathway represents an important new mechanism for autonomic  (cho- 
linergic) control of mammalian heart rate. 
INTRODUCTION 
Rhythmic beating of the mammalian heart originates within primary pacemaker tis- 
sue in the sinoatrial node (SAN). Generation of each spontaneous pacemaker de- 
polarization and action potential depends upon an interaction of several different 
ionic currents, and autonomic regulation of heart rate results from modulation of 
a  number of these conductances by neurotransmitters  (see Irisawa,  Brown, and 
Giles, 1993). Activation of the sympathetic nervous system accelerates heart rate by 
releasing noradrenaline, which then binds to [3-adrenergic receptors and increases 
both the L-type Ca  2+ current, IC~(L), and the hyperpolarization-activated inward cur- 
rent,/t (see Giles and Shibata, 1981; Brown, 1982; Tsien et al., 1986; Hartzell, 1988; 
Irisawa et al., 1993; DiFrancesco, 1993). Conversely, stimulation of the parasympa- 
thetic (vagus) nerve releases acetylcholine (ACh), which decreases heart rate by (a) 
directly activating a K  + current, IK(ACh), and inhibiting/land by (b) antagonizing the 
effects of noradrenaline  by reducing IcatL), the so-called indirect effect (Hartzell, 
1988: Irisawa et al.,  1993; DiFrancesco, 1993). This negative chronotropic effect of 
ACh in mammalian  heart is mediated by the M2 subtype of muscarinic receptors 
(Hartzell, 1988). 
A number of different membrane-bound,  heterotrimeric  GTP-binding proteins 
(G proteins) participate in the signal transduction cascade initiated by sympathetic 
and parasympathetic stimulation  (Gilman, 1987; Brown, 1990; Eschenhagen,  1993). 
For example, the G protein  C~ mediates ~adrenoceptor stimulation  through  two 
principal  pathways. One of these is a  membrane-delimited  or direct pathway in 
which there are interactions  between C~ and some of the ion-selective channels, 
e.g.,/land  ICa<L) (Brown, 1990; but see Clapham,  1994). This direct pathway does 
not involve biochemical second messengers. In contrast, the indirect pathway me- 
diated by C~ requires activation of adenylyl cyclase, which results in increased cAMP 
levels, stimulation  of cAMP-dependent protein  kinase  (PKA), and an increase in 
the  phosphorylation  of a  number  of target  proteins,  including  ICa(L) channels HAN ET AL.  Nitric Oxide and Cholinergic Modulation of Heart Rate  47 
(Hartzell, 1988; McDonald, Pelzer, Trautwein, and Pelzer, 1994). Both the direct 
and the indirect stimulatory effects are decreased after activation of the inhibitory 
G protein (Gi), which couples M~ receptors to at least three different membrane 
currents: II~(ACh) and/f, which are inhibited directly, and ICa(L), which is inhibited in- 
directly (Gilman, 1987; Hartzell, 1988; Brown, 1991; DiFrancesco, 1993; Irisawa et 
al., 1993; Eschenhagen, 1993; Clapham, 1994). 
In the myocardium, the indirect action of ACh is thought to be mediated by a 
pertussis  toxin-sensitive  G  protein,  Gi,  which is  coupled  to  M~  receptors  (He- 
scheler, Kameyama, and Trautwein, 1986; Fischmeister and Shrier, 1989; Nakajima, 
Wu, Irisawa, and Giles, 1990). However, many details of the mechanism by which 
Gi inhibits Ica0.  ) are still unresolved (Fleming, Wisler, and Watanabe, 1992; Eschen- 
hagen, 1993). Although high concentrations of the Or.  i subunit of Gi directly inhibit 
adenylyl cyclase, this inhibitory effect is only partial and is dependent on the sub- 
type of this enzyme (Taussig, Iniguez-Lluhi, and Gilman, 1993). The [3~/subunits 
from Gi can directly inhibit the type-I brain adenylyl cyclase, but this isoform has 
not been identified in heart (Tang and Gilman, 1991), suggesting that other mech- 
anisms (in addition to adenylyl cyclase inhibition)  must be involved in the ACh- 
induced inhibition of Ica(L). A plausible alternative is that the ACh-induced attenua- 
tion of ICaIL  ) is mediated by cGMP (Hartzell,  1988).  cGMP interacts with at least 
three intracellular sites:  cGMP-regulated ion channels, cGMP-dependent protein 
kinase  (PKG), and cGMP-regulated cyclic nucleotide phosphodiesterases  (PDEs) 
(Lincoln and Cornwell, 1993). A cGMP-stimulated PDE that hydrolyses both cAMP 
and cGMP is present in heart (Hartzell, 1988; Beavo and Reifsnyder, 1990). In am- 
phibian  cells, cGMP activates a  cGMP-stimulated cAMP-specific PDE that hydro- 
lyses cAMP and thereby decreases /Ca(L) after it has been augmented by cAMP- 
elevating agents, e.g.,  fl-adrenergic agonists  (see Hartzell,  1988).  On  the other 
hand, a cGMP-dependent protein kinase plays a major role in the cGMP-induced 
decrease in  /Ca(L) in  mammalian myocardium (Levi, Alloatti,  and Fischmeister, 
1989; Mery, Lohmann, Walter, and Fischmeister, 1991; Mery, Pavoine, Belhassen, 
Pecker, and Fischmeister, 1993). 
/Ca(L) is essential for normal pacemaker activity (Irisawa et al., 1993). Modulation 
of this current therefore represents an important mechanism for the autonomic 
control of heart rate. It is known that "physiological" vagal stimulation by a  low 
dose of ACh significantly decreases the spontaneous firing rate without changing 
the maximum diastolic potential of the SAN, as expected for a selective inhibition 
of/Ca(L) (see Irisawa et al.,  1993).  However, the signal transduction pathway that 
leads to this ACh-induced attenuation of/Ca(L) has not been investigated in detail in 
the SAN of the mammalian heart (Petit-Jacques, Bois, Bescond, and Lenfant, 1993, 
1994). 
Muscarinic receptor activation by ACh is known to release nitric oxide (NO), and 
recent evidence has demonstrated that NO is an important second messenger in- 
volved in mediating the actions of neurotransmitters in the cardiovascular and cen- 
tral nervous systems (Bredt and Snyder, 1990;  Bredt, Hwang, and Snyder, 1990; 
Moncada, Palmer, and Higgs,  1991;  Flnkel, Oddis, Jacobs, Watkins, Hattler, and 
Simmons, 1992;  Calver, Collier, and Vallance, 1993;  Dinerman, Lowenstein, and 
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(NOSs),  have  been  identified  in  myocardial  tissues  (Klimaschewski,  Kummer, 
Mayer,  Couraud,  Preissler,  Philippin,  and  Heym,  1992)  and  cardiac  myocytes 
(Schulz, Smith, Lewis, and Moncada, 1991; Schulz, Nava, and Moncada, 1992), but 
the physiological significance of NO synthesis remains unclear. In many different 
preparations,  NO activates guanylyl cyclase and generates cGMP. Indeed,  in cul- 
tured neonatal rat ventricular myocytes, agents known to inhibit NO synthase pre- 
vent the negative inotropic effect of ACh  (Balligand, Kelly,  Marsden, Smith, and 
Michel, 1993). 
Recently, we (Han et al.,  1994)  have demonstrated that the cholinergic inhibi- 
tion of IC~(L) in isolated single SAN cells can be mimicked by an NO donor and that 
ACh cannot reduce IC~(L) if NOS is inhibited. NO is therefore essential for the phys- 
iological control of heart rate occurring in the presence of adrenergic tone. How- 
ever, the biochemical signaling pathways subsequent to NO generation remain un- 
defined. In the current study,  the following questions were addressed:  (a) can NO 
that is released by cholinergic stimulation activate guanylyl  cyclase?  (b) Is cGMP in- 
volved in the carbamylcholine-NO inhibition of IC~(L)? (C) Can PKG or the cGMP- 
stimulated cAMP-specific PDE mediate carbamylcholine-NO attenuation of isopro- 
terenol-stimulated/Ca(L)? 
METHODS 
Cell Isolation 
The technique used for isolation of single cells was the same as that described previously  (Han, 
Habuchi, and Giles, 1994a; Han, Shimoni, and Giles, 1994b). 
Solutions 
The bicarbonate-buffered Tyrode's solution used for Langendorff perfusion of the whole heart 
contained (in millimolar): 121 NaCI, 5.0 KC1, 2.8 sodium acetate, 1.0 MgCI~, 1.0 Na2HPO4, 24 
NaI-ICOs, 5.5 glucose,  and 1.0 CaCI~. This solution was equilibrated with 95% O~ and 5% CO~ 
(pH 7.4). The KB solution (Isenberg and Klockner, 1982) used for storing the cells contained (in 
millimolar): 90 potassium glutamate, 10 potassium oxalate,  25 KCI, 10 KH~PO4, 0.5 EGTA, 1.0 
MgSO4, 20 taurine, 5 HEPES  (~:2-hydroxyethylpiperazine-bg2-ethanesulfonic  acid), and 10 glu- 
cose  (pH adjusted to 7.2 with KOH). The HEPES-buffered  Tyrode's solution in which all experi- 
ments were performed contained (in millimolar): 145 NaCI, 5.4 KCI, 1.0 MgCIg, 1.0 Na2HPO4, 5.0 
HEPES, 1.8 CaCI~, and 10 glucose (pH adjusted to 7.4 with NaOH). 
Recording Methods and Data Acquisition 
In most experiments, the nystatin (0.4 mg/ml) perforated patch technique (Horn and Marty, 
1988) in the whole-cell configuration (Hamill, Marty, Neher, Sakrnann, and Sigworth,  1981) was 
used to current and voltage clamp these cells. The pipette solution contained (in millimolar): 140 
KC1, 6 NaCI, 1 MgCI~, and 5 HEPES  (pH was adjusted to 7.2 with KOH). DC resistance was 1-3 
MI~. Nystatin was first dissolved in dimethylsuffoxide and then added to the pipette solution. In a 
few experiments, the conventional  suction microelectrode ruptured patch whole-cell method was 
used. In these experiments, the pipette solution included (in millimolar):  95 potassium aspartate, 
30 KCI, 5 HEPES, 3 Na2phosphocreatine, 0.1 GTP (Na), 3 KeATP, 10 EGTA (ethyleneglycol-bis-(fl- 
aminoethylether)-N,N,N'N'-tetraacetic acid),  1 CaCI~, and  1 MgCI~ (pH  adjusted to  7.2 with 
KOH). The electrode resistance was between 2 and 4 M~. All recordings were made at 32-33~ HAN ET AL.  Nitric Oxide and Cholinergic  Modulation of Heart Rate  49 
Membrane currents were digitized at 2.5 kI-Iz. The volume of the recording chamber was 0.5 ml, 
and a constant flow rate of 1.5 ml/min was used to supeffuse the cells. 
Drugs and Chemica/s 
Isoproterenol (ISO), carbamylcholine  (CCh), L-arginine, nystatin, dimethylsulfoxide, methylene 
blue, 3-isobutyl-l-methyl-xanthine  (IBMX), and 8-bromoguanosine-3',5'-cyclic  monophosphate 
(8-Br-cGMP) were purchased from Sigma Chemical Co. (St. Louis, MO). 3-Morpholino-sydnon- 
imine (SIN-l) was obtained from Molecular Probes, Inc. (Eugene, OR). 8-(4-Chlorophenylthio)- 
guanosine-Y,5'-cycfic monophosphate (8-ctrr-cGMP) and 8-(4-chlorophenytthio)-adenosine 3',5'- 
cyclic monophosphate (CPT-cAMP) were from BIOLOG (LaJolla, CA.). L-Nitro-arginine methyl 
ester (L-NAME)  was purchased from BACHEM, Inc. (Torrance, CA). NG-monomethyl-~arginine, 
monoacetate (L-NMMA) was obtained from Calbiochem  Corp.  (San Diego, CA). 6-Anilino-5,8- 
quinolinedione (LY83583) was a gift from Eli Lilly and Co. (Indianapolis, IN). 
Statistics 
Statistical significance was evaluated using an unpaired t test, where appropriate. Means with val- 
ues of P < 0.05 were considered to be significantly different. 
RESULTS 
NO Involvement in Muscarinic Cholinergic Inhibition of lc~L~ 
In a previous short communication (Hart et al., 1994), we demonstrated that in rab- 
bit SAN cells, inhibition of NOS by incubation in L-NMMA--containing Tyrode's so- 
lution for 10-20 rain resulted in complete loss of the ability of CCh to attenuate 
Ice,n). In the current study, we first confirmed this finding using a different NOS in- 
hibitor, L-NAME (see Moncada,  1992). Fig. 1 shows a typical set of results. To ob- 
tain a consistent inhibitory effect, the SAN cells had to be incubated with relatively 
high concentrations of L-NAME (0.2-1 raM)  for a long period (at least 3 h). This 
may be because L-NAME is an esterified analogue of arginine and must be deesteri- 
fled before it is able to act on NOS (see Moncada, 1992). The rate of action of the 
appropriate intracellular esterase(s) may account for the necessity of high concen- 
trations of L-NAME and lengthy exposure times, which have both been described 
previously (Balligand et al., 1993). 
Fig.  1 compares results obtained under control conditions.  (Fig.  1 A)  and after 
incubation in L-NAME (Fig. 1 B). The three superimposed current traces in Fig. 1 A 
show that ISO (1 I~M) enhanced Ice,n) (a and b) and that CCh (1 I~M) markedly at- 
tenuated this effect, as well as producing an outward shift in the holding current (c) 
that is due to activation of IKCAeh). Fig. 1 B shows corresponding current traces from 
a different cell that had been incubated in 1 mM L-NAME for 4 h. Under these con- 
ditions, ISO enhanced Ic~r  (a and b), but CCh no longer attenuated it. Note, how- 
ever,  that  the  outward  current,  IKCACh), still  developed after CCh  treatment  (c). 
When the NOS inhibitor L-NMMA was used in this protocol, the pattern of results 
shown in Fig. 1, A and B, could be obtained in the same cell (Han et al., 1994). This 
could not be done with L-NAME,  because the inhibitory action of this compound 
required a very long preincubation  (before recording), and its effects were very 
slow to wash off. Fig. 1 C provides a summary of these effects, expressed as the per- 50  THE JOURNAL  OF GENERAL  PHYSIOLOGY"  VOLUME  106  ￿9 1995 
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FIGURE  1.  Effects of CCh on the ISO-stimulated/Ca(L). In this and subsequent experiments (Figs. 
2--9), /Ca(L) ~  augmented by application of the ~adrenergic agonist ISO and was activated from a 
holding potential of -40 mV by applying 200-ms depolarizing steps to 0 mV at 0.067 Hz. (A) Su- 
perimposed current traces obtained in control (a), ISO (1 p.M) (b), and ISO + CCh (1  p.M) (c). 
The outward shift in the holding current reflects the activation of/K(ACh)- (B) The same procedure 
was repeated in a different cell, which had been preincubated with 1 mM L-NAME for 4 h. In this 
case, ISO still enhanced/Ca(L)  (b), and CCh shiftgd the holding current (IKtAC~)),  but did not atten- 
uate/Ca(L) (C)" (C) Summary of the mean ( - SEM) changes in/Ca(L) (as a percentage of the current 
in ISO alone), produced by CCh alone, by CCh after incubation in L-NAME, and by CCh after co- 
incubation in L-NAME and 1 mM L-arginine.  Note that L-NAME incubation prevents the attenua- 
tion of/Ca(L) by CCh, and the addition of L-argdnine to L-NAME restores the attenuation by CCh. 
cent  reduction  (mean  -+  SEM)  of ISO-stimulated  ICaCL). CCh  alone  reduced  peak 
amplitude  to 57 +_ 4%  of its magnitude  in ISO  (n =  24). After L-NAME incubation, 
peak  amplitude  of Ica was  113  +  7%  (n  =  11),  owing  to  the  inhibitory  effect  of 
L-NAME on NOS and the resulting decreased NO production.  Finally, note that the 
coincubation  of cells in L-NAME with  1 mM L-arginine  (the endogenous  substrate 
of NOS)  restored  the  ability  of CCh  to  attenuate  Ica~L), i.e.,  /Ca(L) Was  reduced  to HAN ET AL.  Nitric Oxide and Cholinergic Modulation  of Heart Rate  51 
57 --- 6%  (n =  4). The ability of CCh to attenuate/Ca(L)  and of atropine  to reverse 
this attenuation  (data not shown), after up to 6  h  of incubation  in E-NAME, indi- 
cate  that this NOS inhibitor does not directly interfere  with  other actions of the 
muscarinic agonist (e.g., its binding to receptors). Thus, although it has been sug- 
gested that I.-NAME may act as a  muscarinic antagonist  (Buxton, Cheek, Eckman, 
Westfall, Sanders, and Keef, 1993), we find no evidence for this in SAN cells. 
Our earlier work demonstrated that the NO donor SIN-1 had no effect in the ab- 
sence of ISO, but that it attenuated ISO-stimulated/Ca(L) and did not further reduce 
IC~(L) after maximal inhibition by CCh  (Han et al.,  1994). A  prediction from these 
earlier  results was that SIN-l, by directly supplying NO  (bypassing NOS),  should 
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FIGURE 2.  Effects  of CCh  (1  p.M) and the 
NO donor SIN-1 (0.1 mM) on ISO-stimulated 
IC~(L) in a SAN cell pretreated with L-NMMA. 
(A) Time course of changes in IC~(L)  and hold- 
ing current in  response  to test agents. The 
horizontal bars denote the dine during which 
each  drug was  applied.  In  this  and  subse- 
quent figures, open circles  (O) denote ICa(L) 
and  closed  circles  (Q)  denote  the  holding 
current level at -40 mV. The cell had been 
incubated with L-NMMA (0.1 mM) for 20 min 
before recording was initiated.  The current 
records at the time points marked a~ b, c, and 
d correspond to the superimposed traces in 
B. (B) Superimposed current traces obtained 
in control (a), ISO (b), ISO + CCh  (c), and 
ISO + CCh + SIN-1 (d)  soludons. Note that 
whereas  L-NMMA treatment  prevents  the 
CCh attenuation of/Ca(L), it does not prevent 
the SIN-l-induced decrease in lC~(L). 
still attenuate  /C~(L) in the presence of the NOS inhibitors.  In the current experi- 
ments  (Fig. 2), we found when CCh-induced attenuation  of IC~(L) was inhibited by 
L-NMMA, addition of SIN-1 to the same cell indeed could still reduce/Ca(L). 
Is cGMP Involved in These Actions of  NO? 
In  many tissues,  NO  can  activate  guanylyl cyclase(s)  (GC),  which  then  generates 
cGMP. We therefore attempted to inhibit the action of NO on Ica(e) in myocytes from 
rabbit SAN by applying methylene blue, a compound that can block NO-induced ac- 
tivation of GC (Michel and Smith, 1993; Brady, Warren, Poole-Wilson, Williams, and 52  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  .  1995 
Harding,  1993; Mery et al.,  1993). In six cells, 5--10 vLM methylene blue completely 
blocked the action of CCh on IC~(L) in SAN cells. The peak amplitude  of/Ca(L) was 
97 -- 3%  (n =  fi)  of the value in ISO plus methylene blue.  However, in addition to 
blocking the inhibitory effect of CCh on ICatL), the activation of IK(ACh)  was also inhib- 
ited completely. This pattern of results is illustrated in Fig. 3, A and B. When CCh was 
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FIGURE 3.  Effects of methylene blue (MB; 10 p.M) on CCh (1 p.M)-induced inhibition of/Ca(L). 
(A) Methylene blue blocks the CCh-induced inhibition of ISO-stimulated/(Ca(L). Note that there is 
also no activation of IK(ACh), indicated by the lack of shift in the holding current. The horizontal 
bars denote the time during which each drug was applied.  (B) Superimposed current records at 
the time points marked a, b, and c in A. Traces are from control (a), ISO + MB (b), and ISO + 
MB +  CCh (c) solutions. (C) Addition of methylene blue after CCh increases/Ca(L) and reduces 
IK(A~), thus, reversing both effects  of CCh  (different ceil).  (D) The effects of CCh in a cell in 
which methylene blue (25 I~M) was included in the pipette solution (whole-cell recording without 
nystatin). The outward shift in holding current was present, yet the attenuation of/Ca(L) was still 
prevented by methylene blue. (See text). 
applied first, the subsequent addition of methylene blue reversed both CCh effects; 
i.e., it increased/Ca(L),  and shifted the holding current inward,  to its pre-CCh level. 
This result, seen in three cells, is shown in Fig. 3  C. A plausible explanation for these 
findings is that methylene blue can act as an antagonist at the muscarinic receptor. If 
this is the case, methylene blue-induced blockade of CCh effects cannot be taken as HAN ET AL.  Nitric Oxide and Cholinergic Modulation of Heart Rate  53 
convincing evidence for an NO-induced activation of guanylyl cyclase in the muscar- 
inic action of CCh.  To address this question,  two series of experiments were per- 
formed. In the first, the suction electrode whole-cell method of recording was used, 
to enable intracellular dialysis with methylene blue. Although the rundown of/Ca(L) 
tends to be faster when using this method, the pipette solution used (see Methods) 
allowed sufficiently stable  recordings  over the  required  time period  (15--25 min). 
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FmUv.E 4.  Effects of methylene blue (MB) on the action of the NO donor SIN-1. (A) Time course 
of/C~(L) (O) and holding current (0) before (a) and after addition ofISO (b). The subsequent addi- 
tion of 10 0M methylene blue had no direct effect, but prevented the attenuation Of/ca(L)  by 0.1 mM 
SIN-1 (c). (B) Superimposed current traces from corresponding times a, b, and c in A. (C) In a differ- 
ent cell, 5 vLM methylene blue prevented the attenuation of ISO-stimulated/C~(L)  by 0.1 mM SIN-1. 
After methylene blue washoff, 0.1 mM SIN-1 in the same cell greatly attenuated/Ca(L). (D) Summary 
of the effects of methylene blue on the attenuation of IC~(L)  by CCh and SIN-1. The bars represent 
the amplitude of IC~(L)  as a percentage, reladve to that in ISO alone. 
With this protocol, in eight cells, CCh activated IK(ACh) (because no methylene blue 
was present in the perfusate), yet it failed to attenuate ICatL) (Fig.  3 D). The mean 
value of peak ICatL) after CCh addition was 95 _+ 3% of the value in ISO alone, which 
strongly supports  NO involvement in  CCh  action.  In  the  second series of experi- 
ments, SIN-l, an NO donor, was used in an independent test of this interpretation of 
the effects of methylene blue. SIN-1 directly releases NO, thus bypassing muscarinic 54  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9  VOLUME 106 ￿9 1995 
receptor and G protein activation. In the presence of ISO, SIN-1 reduced peak Ic~(L> 
to 58 _  4% of the amplitude in ISO alone (n =  19). This effect of SIN-1 was blocked 
by methylene blue (n =  5; Fig. 4, A and B), as shown previously by Mery et al. (1993). 
The peak IC~(L) in SIN-1 in the presence of ISO and methylene blue, was 98 ___ 4% of 
its magnitude in ISO and methylene blue. Fig. 4  Cshows an example in which SIN-1 
failed to affect IC~(L> in the presence of methylene blue. Thereafter,  methylene blue 
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FmURE 5.  Effects of LY83583 (30 I~M) on CCh (1 p.M)-induced inhibition of/ca(L). (A) LY83583 
did not affect the increase in current by ISO (b), but blocked the CCh-induced inhibition of ICC~tL  ) 
(c). The horizontal bars denote the time during which each drug was applied. (B) Superimposed 
current records at the time points marked a (contr00, b (IS{) + LY83538), and c (ISO + LY83538 + 
CCh) in A. Note that LY83583 did not prevent the CCh-induced activation of IK(AO~). (C) In the 
same cell, LY83538 was washed off and CCh was reapplied in the presence of ISO alone. In the ab- 
sence of LY83538, CCh reduced/ca(L).  (D) Superimposed current traces corresponding to C, from 
points d (ISO) and e (ISO + CCh), showing the reduction in Ica(LI. 
was washed out, and a  second exposure to SIN-1 then strongly attenuated  the cur- 
rent. Fig. 4 D summarizes data describing the reduction in Ic~(L)  by CCh and SIN-1 (as 
a percentage relative to the amplitude of IC~(L) in ISO), in the presence and absence 
of methylene blue. 
Guanylyl cyclase activation will elevate  intracellular  cGMP, which is one of the 
mediators  of the  muscarinic  cholinergic  effects on IC~<L) in working myocardium HAN ET AL.  Nitric Oxide and Cholinergic Modulation of Heart Rate  55 
(Watanabe and Besch, 1975; Hartzell, 1988; Levi et al., 1989).  To determine if this 
biochemical cascade is involved in the SAN, cells were exposed to ISO and CCh in 
the presence of LY83538, a compound that strongly inhibits both basal and CCh- 
stimulated cGMP production (Schmidt, Sawyer, Truex, Marshall, and Fleisch, 1984; 
Diamond and Chu, 1985; Mulsch, Luckhoff, Pohl, Busse, and Bassenge, 1989).  In 
11 cells, LY83538 (30 ~M) did not significantly  change the enhancement of/CarL) by 
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FIGURE  6.  Effects of LY83538 on SIN-1  attenuation  of/Ca(L).  (A) Time  course of ICa(L) (O) and 
holding current (O) in control  (a), ISO +  LY83538  (b), and after exposure to 0.1 mM SIN-1  (c). 
(B) Superimposed  current traces corresponding  to points oo b, and c in A.  (c), In a different cell, 
0.25 mM SIN-1 was without effect on IC~(L) in the presence of ISO +  LY83538; however, SIN-1 at- 
tenuated IC~(L) after washout of LY83538.  (D) Summary of the effects of LY83538 on the attenua- 
tion of Ic, tL) by CCh and by SIN-1.  Note that LY83538 prevents attenuation  of ICa(L) by CCh and 
SIN-1. 
ISO, but it blocked the inhibitory action of CCh on this current, without altering 
the activation in IKtACh). The mean value of ISO-stimulated IcatL  ) after exposure to 
CCh, in the presence of LY83538, was 92 -  5% of the value in ISO. An example of 
this pattern of results is shown in Fig. 5. Fig. 5 A shows the time course of changes 
in the holding current and in /Ca(L) after exposure to CCh. Fig. 5 B shows current 
traces recorded at the times indicated. In this and four other cells,  LY83538 was 56  THE JOURNAL OF GENERAL  PHYSIOLOGY ￿9 VOLUME  106  ￿9 1995 
washed off and the cell was reexposed to CCh. This restored the attenuating effect 
of CCh on ICa(L), as shown in Fig. 5, C and D. These findings strongly suggest that in 
rabbit SAN, CCh triggers the production of cGMP and that this elevation in cGMP 
can inhibit ICatL ). 
In other experiments  (12 cells), LY83538 (30 I~M) blocked the inhibitory action 
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FIGURE 7.  Effects of the membrane-permeable, nonhydrolyzable cAMP analogue CPT~AMP on 
CCh action. (A) Time course of changes in IC~(L) (O) and holding current (O) in response to each 
drug application. The horizontal bars indicate the time during which each drug was applied. The 
current records denoted by a-f correspond to the traces in B and C. Addition of 0.2 mM GPT- 
cAMP to the superfusate increased IC~(L) (b), and the subsequent addition of CCh (1 p.M) did not 
attenuate it (c), although CCh did activate/g(Ach) (outward shift in holding current). When CPT- 
cAMP was replaced by ISO (d), a second exposure to CCh produced the normal/C~(L) attenuation 
(e). Switching back to CPT-cAMP (in the presence of CCh) reversed this attenuation (f), suggest- 
ing that/Ca(L) can be attenuated only when the degradable cAMP is present.  (B) Superimposed 
current records corresponding to a-c in A. (C) Superimposed current traces corresponding to 
d-fin A. 
of SIN-1 on ISO-stimulated/Ca(L)* The mean magnitude of/Ca(L) in SINol alone was 
58 -+ 4% of its magnitude in ISO; and after application of LY83538, itwas 103 _+ 4% 
(Fig. 6, A and B). In two cells, LY83538 was washed off, and a  second exposure to 
S1N-1 also produced the expected attenuation in ICa(L) (Fig. 6  C). A summary of the 
effects of LY83538 on the attenuation  of ICa(L) by both CCh and SIN-1 is shown in HAN ET AL.  Nitric Oxide and Cholinergic  Modulation of Heart Rate  57 
Fig. 6 D. These findings further support our working hypothesis, in which NO pro- 
duction leads to an elevation of cGMP, which then results in the attenuation of 
Ica(L) (see Discussion and Fig. 10). 
To obtain more information about the biochemical mechanisms responsible for 
the observed muscarinic attenuation of ICa{L), the biochemical events following ele- 
vation in cGMP were investigated. In frog myocardium, cGMP stimulates a  PDE 
that augments cAMP  breakdown  (Hartzell,  1988;  Simmons  and  Hartzell,  1988; 
Mery et al., 1993), thereby attenuating the ISO-stimulated ICa{L). In mammalian ven- 
tricle, on the other hand, cGMP activates (a cGMP-dependent protein kinase) PKG, 
which leads to a reduction of/CalL  ) (Levi et al., 1989; Mery et al., 1991). We there- 
fore studied whether either of these two mechanisms are operative in mammalian 
cardiac primary pacemaker cells. 
Effects of Cyclic Nucleotide Analogues 
Cyclic nucleotide analogues that are not hydrolyzed by intracellular PDE provide a 
useful experimental approach for evaluating the possible involvement of cyclic nu- 
cleotide--dependent PDE  in  the observed  effects of NO.  We exposed  SAN  cells 
(n =  6)  to a  membrane-permeable analogue of cAMP, CPTw.AMP,  which directly 
activates PKA and is not degraded by PDE, thus resulting in a marked increase in 
Ica{e). The effect of this compound on Ica{L} is similar to that of ~adrenergic ago- 
nists. However, it bypasses the receptor-dependent,  G-mediated activation of ade- 
nylyl cyclase, and its effects are maintained, as opposed to transient. In six cells, the 
mean augmentation of Ica~L) Was 183.5  +-- 25.8% of the control magnitude. More- 
over, after CPT-cAMP (0.2 raM), Ica{L) was no longer reduced by CCh. The mean 
current amplitude after CCh treatment was 96.1  _  4.0% of the prior value (Fig. 7). 
In two cells, CPTw.AMP was washed out and ISO was then introduced (point d in 
Fig. 7, A and C). Under these conditions (in the presence of normal ~adrenergic 
activation), CCh markedly reduced ICa{L) (point e in Fig. 7, A and C). Subsequently, 
after ISO was removed and CPTw.AMP was added, the inhibitory action of CCh on 
/Ca(L)  was  partially reversed  (point fin Fig. 7, A and C). This set of results implies 
that/CalL) can be attenuated by CCh only when cAMP can be degraded by a PDE. 
Note that the outward current, IK{ACh),  activated by CCh is present under both con- 
ditions (CPT-cAMP and ISO), i.e., it is not dependent on these cyclic nucleotide 
levels. These results rule out any site of action that is at or subsequent to the activa- 
tion of PKA in the CCh/NO-induced attenuation of ICa{L). For example, the en- 
hancement of phosphatase  activity and  the  resulting dephosphorylation  of the 
IcatL) channel would still occur in the presence of CPTw.AMP. 
CCh-induced inhibition of Ica{L) may result from an inhibition of adenylyl cyclase, 
as has been suggested previously in mammalian ventricle and atrium (Hescheler et 
al., 1986; Nakajima et al., 1990). This is thought to occur through muscarinic acti- 
vation of G i, which directly inhibits the G~ stimulation of adenylyl cyclase resulting 
from [$-adrenergic receptor occupation. This possibility was evaluated (n =  5)  in 
rabbit SAN cells, to which ISO was added with  (or after exposure to)  10-20  p,M 
IBMX, a nonselective inhibitor of a number of different PDEs. IBMX was applied 
with ISO to ensure that adenylyl cyclase was also activated. The combination re- A 
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suited in a mean increase in/Ca(L) to 162.5 -+ 8.5% of its control value. Subsequent 
addition of CCh produced no inhibitory effect on Ic~(g) (the mean value after CCh 
was 118.8 _+ 5.7% of the value before CCh); however, an outward shift in the hold- 
ing current, signifying activation of IK<ACh),  was present.  IBMX was then washed out 
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FIGURE 8.  Effect of the nonspecific PDE inhibitor IBMX on CCh actions.  (A) Time course of 
changes in ICa<L) (C)) and holding current (0) in response to each drug. The horizontal bars indi- 
cate  the  time  during which each drug was applied.  The  current records denoted by the  a-j 
correspond to the traces in B and C. In this cell, ISO was added with 20 tiM IBMX, resulting in an 
increase in IC~(L) (b). CCh (1 p.M) did not change IC~(L) under these conditions (c) but still acti- 
vated IK(ACh). When IBMX was washed out (still in ISO; d), a second exposure to CCh strongly in- 
hibited Ica(L) (e). Reintroducing IBMX reversed this CCh-induced attenuation (f), presumably by 
preventing the stimulation of PDE by CCh (see text). Note that IBMX seems to potentiate the ef- 
fects of CCh on IK(ACh) (the outward shift in c is unusually large, and at f, IBMX produces a second- 
ary shift, with no change in CCh concentration). (B) Superimposed current records correspond- 
ing to o-c. (C)  Superimposed current traces corresponding to points d-f 
(point d in Fig. 8, A and C), and when CCh was added for a second time, strong at- 
tenuation of IC~(L) was observed (point e in Fig. 8, a  and C) . Thereafter,  reapplying 
IBMX reversed this effect of CCh (point fin  Fig. 8, A and C). These results suggest 
that CCh does not reduce/Ca(L) by directly inhibiting adenylyl cyclase, because this HAN ET AL.  Nitric Oxide and Cholinergic Modulation of Heart Rate  59 
would have occurred even in the presence of IBMX. These findings also support 
the hypothesis that CCh inhibits Ic~o.i only when cAMP breakdown is enhanced, 
e.g., by activating the cGMP-stimulated PDE. 
In our final series of experiments, two membrane-permeable analogues of  cGMP, 
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FIGURE 9.  Effects of two membrane-permeable, nonhydrolyzable analogues of cGMP, 8-bromo- 
cGMP and 8-CPT-cGMP, on CCh acdons.  (A) 8-CPT-cGMP (0.25 raM) has no inhibitory effect on 
ISO-stimulated IC~<L). (B)  8-Br-cGMP (0.2 mM)  also does not inhibit the ISO-stimulated Ic~(L). In 
both A and B, the top row shows the time course of changes in Ic~<L> (O) and holding current (O) 
in response  to each test agent and  the bottom  row shows the superimposed  current traces ob- 
tained at the dine points marked a-d above. The horizontal bars denote the time during which 
each agent was applied. Neither 8-CPT-cGMP (c) nor 8-Br-cGMP (c) inhibits ISO-stimulated IC~(L) 
(b).  Addition of CCh  (1  I~M) produced the expected attenuation  of IC~(L) along with the activa- 
tion of IK(ACh) (d). 
8-Br-cGMP and 8-CPT-cGMP, were used. Both of these analogues strongly and se- 
lectively activate PKG and are insensitive to breakdown by PDE  (Lincoln and Corn- 
well, 1993; Geiger, Nolte, Butt, Sage, and Walter, 1992). Results from these experi- 
ments are shown in Fig. 9. Neither 8-Br-cGMP nor CPT-cGMP, when added after 
ISO, had an inhibitory effect on ISO-stimulated Ira(L). The mean (n =  5) peak Ic~(L) 
amplitude in 8-Br-cGMP was  103.8  _+  2.2%  (relative to ISO alone), and that in 60  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  ￿9 1995 
8-CPT-cGMP was 93.9  _  3.0%  of the amplitude  in ISO alone  (n =  4),  suggesting 
that PKG activation cannot attenuate  ICe,L). In the presence of 8-Br-cGMP to CCh 
reduced IC~tL) tO 56.2 -- 7.1% of the value in ISO; and in the presence of 8 CPT-cGMP 
IC~tL) was reduced to 61.4 _  9.6%. These findings suggest that cGMP resulting from 
CCh actions can reduce ICe,L), presumably by activation of a  PDE which enhances 
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FIGURE 10.  Diagram  of  our 
working  hypothesis  describing 
the  cellular  signaling  pathways 
for NO-mediated cholinergic in- 
hibition of/C~(L) in the presence 
of  adrenergic tone in rabbit SAN. 
Activation of  NOS after the bind- 
ing of CCh  to the M~ receptor 
results in NO production. This is 
blocked by L-NMMA  or L-NAME, 
but  this  inhibition  can  be  re- 
versed by application  of excess 
L-arginine. The NO donor SIN-1 
directly  provides  NO,  which 
stimulates  guanylyl cyclase  (GC) 
and elevates  cGMP levels. Gua- 
nylyl cyclase activation  is blocked 
by methylene blue (MB), and formation of cGMP is more selectively inhibited by LY83538. In this 
scheme, cGMP stimulates  both the cGMP-dependent protein kinase (PKG) and the cGMP-stimu- 
lated cAMP-specific PDE. Blocking PDE by IBMX or the application of a nonhydrolyzable cAMP 
analogue, CPT-cAMP, prevents the CCh- or NO-induced reduction of Icale  ). Two cGMP  ana- 
logues that activate PKG without affecting PDE activity do not prevent the reduction of/Ca(L) by 
CCh. In this scheme, it is the cGMP-activated  cAMP-specific PDE that hydolyzes ISO-elevated 
cAMP and decreases the/Ca(L). 
cAMP breakdown. In contrast, the nonhydrolyzable analogues of cGMP that do not 
stimulate this class of PDE are without effect on IC~(L). 
DISCUSSION 
Summary of  Findings 
Our results  from primary pacemaker  (SAN)  cells of rabbit  heart can be summa- 
rized using a  pharmacological/biochemical working hypothesis that describes  the 
cascade of events involved in cholinergic inhibition  of L-type Ca  2+ current,  IC~(L). 
This scheme and the interventions that we have used to test its validity are shown in 
Fig.  10. Under physiological conditions, the attenuation  of IC~<L), which is essential 
for the slowing of heart rate  (Irisawa et al.,  1994),  takes place in the presence of a 
steady  or  background  adrenergic  tone.  Under  these  conditions,  modulation  of 
IC~(L) can occur at very low concentrations of ACh, which activate little  if any out- 
ward K + current, IlqACh) (see Irisawa et al., 1994). In all of our protocols, adrenergic 
tone was mimicked by application  of ISO; and a  relatively high  concentration  of HAN ET AL.  Nitric Oxide and Cholinergic Modulation of Heart Rate  61 
the muscarinic agonist CCh  (1  I~M ) was used to ensure that IKtAChl was also acti- 
vated. IKthChl, which was measured as an outward shift in the holding current (at 
-40  mV), provided an internal control so that a functional muscarinic response 
could be verified in all recordings. 
Three important issues concerning the physiological modulation of IcatL) have 
been clarified by our results. First, the involvement of NO as an obligatory media- 
tor of muscarinic cholinergic responses in the SAN in the presence of ISO was con- 
firmed (see Han et al., 1994). This was done using two different inhibitors of NOS, 
either L-NAME  or L-NMMA.  Preincubation of cells with either compound consis- 
tendy prevented the inhibitory action of CCh on ICalL) and this effect could be over- 
come by coincubation with an excess of L-arginine, the endogenous substrate of 
NOS (Figs. 1 and 2). In addition, the NO donor SIN-l, which can mimic the inhib- 
itory effect ofCCh (Han et al., 1994), was shown to retain its effect in the presence 
of L-NAME or L-NMMA  (Fig. 2). Our results also demonstrate that the effects of 
CCh and of SIN-1 can be blocked by methylene blue, which is known to interfere 
with NO-induced activation of guanylyl cyclase and to decrease cGMP levels (Figs. 3 
and 4).  However, methylene blue blocked the effects of CCh on both /Ca(L) and 
/K(ACh), indicating that this compound has nonspecific effects (possibly muscarinic 
receptor blockade) in addition to inhibition of guanylyl cyclase. 
The  second  important outcome from  our work  is  the  demonstration  that  in 
mammalian SAN cells the effects of CCh and of SIN-1 on/Ca(L) Can be inhibited by 
the compound LY83538. Because LY83538 significantly reduces intracellular cGMP 
levels, this result strongly suggests that the NO-mediated inhibition Of/Ca(L)  involves 
the generation of cGMP in rabbit SAN. Furthermore, LY83583 had no effect on ac- 
tivation of IK~ACh), a muscarinic response that is not dependent on cGMP levels. 
Third, our findings also suggest that cGMP-dependent activation of a cAMP-spe- 
cific PDE is an important step in the indirect muscarinic modulation of IcalL). In- 
creased activity of this isoform of PDE would be expected to decrease cAMP levels 
and reduce the phosphorylation of the L-type Ca  2+ channels (Simmons and Hart- 
zell, 1988). Accordingly, in the presence of nonhydrolyzable analogues of cAMP or 
the nonselective PDE inhibitor IBMX, CCh was without effect (Figs. 6  and 7; see 
also Wang  and  Lipsius,  1994).  This finding rules  out any direct inhibition  of a 
cAMP-dependent protein kinase  (PKA)  by CCh, or a  modulation of biochemical 
events subsequent to activation of PKA, e.g., enhanced dephosphorylation of the 
L-type Ca  ~+ channel by phosphatases.  The lack of an inhibitory effect of CCh on 
/Ca(L) in the presence of ISO and IBMX or the nonhydrolyzable analogue of cAMP 
or CPT-cAMP strongly suggests that the inhibition of adenylyl cyclase by CCh (or el- 
evated cGMP) does not play a significant role in the attenuation of Ic~tL) in rabbit 
pacemaker cells. However, it is conceivable that intracellular cAMP reaches saturat- 
ing levels after exposure to IBMX and ISO, leading to maximal augmentation  of 
Ica~L)- Under these conditions, CCh-induced decreases in the rate of cAMP forma- 
tion might go undetected, because a sufficiently high concentration of cAMP may 
still be present to give maximal IC~IL). To test this possibility, we applied IBMX after 
CCh (Fig. 8, e and f).  Under these conditions, if the major effect of CCh was to in- 
hibit  ISO-stimulated  adenylyl  cyclase,  cAMP  levels  would  be  very  low,  IBMX- 
induced inhibition of PDE would have very small effects, and the resulting increase 62  THE JOURNAL OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME 106  ￿9  1995 
in cAMP and ICa(L)would be expected to be small. In fact, the effects of IBMX on 
/ca(L) were very similar whether it was applied before or after CCh  (see Fig. 8), im- 
plying that  CCh  does  not  act  mainly on  the  adenylyl  cyclase  in  rabbit SAN.  Al- 
though elevated cGMP levels in response to CCh application and/or  NO produc- 
tion can stimulate PKG, this enzyme does not appear to play a  significant role in 
the cholinergic attenuation of IcaiL  ) in rabbit SAN (Fig. 9), because membrane-per- 
meable analogues of cGMP failed to change ICa(L) significantly. This is in contrast to 
the effects of CCb, which markedly reduced ICaIL  ). 
Relation to Previous Work 
The muscarinic modulation of 1Ca(L) is known to involve two different biochemical 
pathways depending upon the species or cardiac tissue being studied.  In mamma- 
lian ventricular cells (Levi et al.,  1989;  Mery et al.,  1991)  cGMP-dependent activa- 
tion of a protein kinase (PKG) is necessary for the reduction in IC~(L). On the other 
hand, in frog myocardium (Hartzell, 1988; Mery et al.,  1993),  the most important 
biochemical  reaction  appears to be  cGMP-induced  stimulation  of a  PDE,  which 
then selectively breaks down cAMP. The resulting reduction in cAMP levels attenu- 
ates  1CalL  ).  Our  data  show  that  in  mammalian  pacemaker cells  the  biochemical 
scheme that has been identified in frog ventricle is operative. 
Limitations of Our Approach 
Our data are consistent with, but do not unequivocally prove, the working hypothe- 
sis outlined in Fig.  10.  For example, if IBMX or 8-CPT~AMP can inhibit adenylyl 
cyclase indirectly,  perhaps  through  a  negative feedback control  mechanism acti- 
vated by very high levels of cAMP (see Iyengar, 1993), no further inhibition of ade- 
nylyl cyclase by CCh would be observed. In addition, a cGMP-induced inhibition of 
PKA or a  cGMP-dependent activation of a  phosphatase that acts directly on  /Ca(L) 
channels might be effective in the presence of cAMP, but conceivably may not oc- 
cur in the presence of the cAMP analogue CPT<AMP. The isoform of the PDE acti- 
vated by cGMP needs to be identified in SAN cells. Further work is also required to 
elucidate how NOS is activated after application of muscarinic agonists. 
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